Literature DB >> 6607943

A multistage model for the action of cytotoxic T lymphocytes in multicellular conjugates.

C A Macken, A S Perelson.   

Abstract

We propose a multistage stochastic model to explain data on the kinetics of target cell lysis by cytotoxic T lymphocytes in multicellular conjugates. A novel feature of our model is that we explicitly consider both the lethal hitting stage and the target cell disintegration stage of the cytolytic process. Further, we allow for the possibility that target cell disintegration is itself a complex process composed of many events. The comparison of our model with the data of other investigators suggests that cytotoxic T cells deliver lethal hits at random to undamaged target cells. Having received a lethal hit, the target cell disintegrates over a variable length of time. The disintegration times of target cells from different conjugates appear to be randomly distributed and to be consistent with a model in which disintegration occurs by at least two major, sequential, rate-limiting events. For conjugates containing one lymphocyte and multiple target cells, the mean rate at which a lethally hit target cell disintegrates is found to be independent of the total number of target cells in the conjugate. Our model predicts that in such multicellular conjugates, individual target cells lyse one by one, on average at approximately 30-min intervals, thus agreeing closely with previously reported experimental observations.

Mesh:

Year:  1984        PMID: 6607943

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Infections prevent the development of asthma--true, false or both?

Authors:  P J Openshaw; G Walzl
Journal:  J R Soc Med       Date:  1999-10       Impact factor: 5.344

2.  Imaging burst kinetics and spatial coordination during serial killing by single natural killer cells.

Authors:  Paul J Choi; Timothy J Mitchison
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

3.  Estimation of the rate of killing by cytotoxic T lymphocytes in vivo.

Authors:  Roland R Regoes; Daniel L Barber; Rafi Ahmed; Rustom Antia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

4.  Real-time detection of CTL function reveals distinct patterns of caspase activation mediated by Fas versus granzyme B.

Authors:  Jinzhu Li; Sarah K Figueira; Alexandra C A Vrazo; Brock F Binkowski; Braeden L Butler; Yasuhiro Tabata; Alexandra Filipovich; Michael B Jordan; Kimberly A Risma
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

5.  On the kinetics and optimal specificity of cytotoxic reactions mediated by T-lymphocyte clones.

Authors:  R Lefever; J Hiernaux; J Urbain; P Meyers
Journal:  Bull Math Biol       Date:  1992-09       Impact factor: 1.758

6.  Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis.

Authors:  V A Kuznetsov; I A Makalkin; M A Taylor; A S Perelson
Journal:  Bull Math Biol       Date:  1994-03       Impact factor: 1.758

7.  Spatial heterogeneity and peptide availability determine CTL killing efficiency in vivo.

Authors:  Thea Hogan; Ulrich Kadolsky; Sim Tung; Benedict Seddon; Andrew Yates
Journal:  PLoS Comput Biol       Date:  2014-09-18       Impact factor: 4.475

8.  Viral proteome size and CD8+ T cell epitope density are correlated: the effect of complexity on selection.

Authors:  Alexandra Agranovich; Yaakov Maman; Yoram Louzoun
Journal:  Infect Genet Evol       Date:  2013-08-15       Impact factor: 3.342

9.  A Dynamically Consistent Nonstandard Difference Scheme for a Discrete-Time Immunogenic Tumors Model.

Authors:  Muhammad Salman Khan; Maria Samreen; Muhammad Asif Khan; Manuel De la Sen
Journal:  Entropy (Basel)       Date:  2022-07-07       Impact factor: 2.738

10.  Revisiting estimates of CTL killing rates in vivo.

Authors:  Andrew Yates; Frederik Graw; Daniel L Barber; Rafi Ahmed; Roland R Regoes; Rustom Antia
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.